77 related articles for article (PubMed ID: 22585480)
21. Localization of the ezrin binding epitope for advanced glycation endproducts.
McRobert EA; Tikoo A; Cooper ME; Bach LA
Int J Biochem Cell Biol; 2008; 40(8):1570-80. PubMed ID: 18203644
[TBL] [Abstract][Full Text] [Related]
22. Strategies for proteomic analysis of non-enzymatically glycated proteins.
Priego Capote F; Sanchez JC
Mass Spectrom Rev; 2009; 28(1):135-46. PubMed ID: 18949816
[TBL] [Abstract][Full Text] [Related]
23. Structural modifications of human albumin in diabetes.
Guerin-Dubourg A; Catan A; Bourdon E; Rondeau P
Diabetes Metab; 2012 Apr; 38(2):171-8. PubMed ID: 22349032
[TBL] [Abstract][Full Text] [Related]
24. The in vitro glycation of human serum albumin in the presence of Zn(II).
Seneviratne C; Dombi GW; Liu W; Dain JA
J Inorg Biochem; 2011 Dec; 105(12):1548-54. PubMed ID: 22071077
[TBL] [Abstract][Full Text] [Related]
25. The in vitro inhibition effect of 2 nm gold nanoparticles on non-enzymatic glycation of human serum albumin.
Seneviratne C; Narayanan R; Liu W; Dain JA
Biochem Biophys Res Commun; 2012 Jun; 422(3):447-54. PubMed ID: 22579685
[TBL] [Abstract][Full Text] [Related]
26. Albumin and immunoglobulin depletion of human plasma.
Jenkins RE; Kitteringham NR; Greenough C; Park BK
Methods Mol Biol; 2008; 425():15-25. PubMed ID: 18369883
[TBL] [Abstract][Full Text] [Related]
27. Mass spectrometry to detect the site specificity of advanced glycation/lipoxidation end-product formation on protein: some challenges and solutions.
Ames JM
Biochem Soc Trans; 2008 Oct; 36(Pt 5):1051-4. PubMed ID: 18793187
[TBL] [Abstract][Full Text] [Related]
28. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
Vasan S; Zhang X; Zhang X; Kapurniotu A; Bernhagen J; Teichberg S; Basgen J; Wagle D; Shih D; Terlecky I; Bucala R; Cerami A; Egan J; Ulrich P
Nature; 1996 Jul; 382(6588):275-8. PubMed ID: 8717046
[TBL] [Abstract][Full Text] [Related]
29. Cathepsins D and L reduce the toxicity of advanced glycation end products.
Grimm S; Horlacher M; Catalgol B; Hoehn A; Reinheckel T; Grune T
Free Radic Biol Med; 2012 Mar; 52(6):1011-23. PubMed ID: 22245096
[TBL] [Abstract][Full Text] [Related]
30. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
Ahmad MS; Pischetsrieder M; Ahmed N
Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical studies on glycation-induced structural changes in human IgG.
Ahmad S; Moinuddin ; Khan RH; Ali A
IUBMB Life; 2012 Feb; 64(2):151-6. PubMed ID: 22241644
[TBL] [Abstract][Full Text] [Related]
32. Maillard reaction products in tissue proteins: new products and new perspectives.
Thorpe SR; Baynes JW
Amino Acids; 2003 Dec; 25(3-4):275-81. PubMed ID: 14661090
[TBL] [Abstract][Full Text] [Related]
33. Novel inhibitors of advanced glycation endproducts (part II).
Rahbar S; Yerneni KK; Scott S; Gonzales N; Lalezari I
Mol Cell Biol Res Commun; 2000 Jun; 3(6):360-6. PubMed ID: 11032758
[TBL] [Abstract][Full Text] [Related]
34. Conformational analysis of human serum albumin and its non-enzymatic glycation products using monoclonal antibodies.
Saito K; Hamano K; Nakagawa M; Yugawa K; Muraoka J; Kuba H; Furukawa K; Azuma T
J Biochem; 2011 May; 149(5):569-80. PubMed ID: 21258068
[TBL] [Abstract][Full Text] [Related]
35. Application of phenylboronic acid modified hydrogel affinity chips for high-throughput mass spectrometric analysis of glycated proteins.
Gontarev S; Shmanai V; Frey SK; Kvach M; Schweigert FJ
Rapid Commun Mass Spectrom; 2007; 21(1):1-6. PubMed ID: 17125156
[TBL] [Abstract][Full Text] [Related]
36. Two-dimensional liquid chromatographic methods to examine phenylboronate interactions with recombinant antibodies.
Zhang B; Mathewson S; Chen H
J Chromatogr A; 2009 Jul; 1216(30):5676-86. PubMed ID: 19540505
[TBL] [Abstract][Full Text] [Related]
37. Alginate as an antiglycating agent for human serum albumin.
Sattarahmady N; Khodagholi F; Moosavi-Movahedi AA; Heli H; Hakimelahi GH
Int J Biol Macromol; 2007 Jul; 41(2):180-4. PubMed ID: 17350677
[TBL] [Abstract][Full Text] [Related]
38. Advanced glycation end products induce specific glycoprotein alterations in retinal microvascular cells.
Rellier N; Ruggiero D; Lecomte M; Lagarde M; Wiernsperger N
Biochem Biophys Res Commun; 1997 Jun; 235(2):281-5. PubMed ID: 9199182
[TBL] [Abstract][Full Text] [Related]
39. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin.
Zoellner H; Hou JY; Hochgrebe T; Poljak A; Duncan MW; Golding J; Henderson T; Lynch G
Biochem Biophys Res Commun; 2001 Jun; 284(1):83-9. PubMed ID: 11374874
[TBL] [Abstract][Full Text] [Related]
40. The sour side of neurodegenerative disorders: the effects of protein glycation.
Vicente Miranda H; Outeiro TF
J Pathol; 2010 May; 221(1):13-25. PubMed ID: 20186922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
